Cargando…
Low-dose rituximab protocol in rheumatoid arthritis—outcome and economic impact
OBJECTIVES: A significant proportion of RA patients, particularly those associated with poor prognostic factors, fail on conventional DMARDs (cDMARDs). Although rituximab (RTX) has been effective in these patients, the cost of therapy makes it unaffordable, particularly in poor and developing countr...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878847/ https://www.ncbi.nlm.nih.gov/pubmed/33605940 http://dx.doi.org/10.1093/rap/rkaa077 |